Dr. Linda T. Vahdat

Dr. Linda T. Vahdat, MD, MBA, is a nationally recognized medical oncologist specializing in breast cancer, with a particular focus on triple-negative breast cancer and novel therapeutic development. She serves as Chief of Medical Oncology and Clinical Director of Cancer Services at Norwalk Hospital and is a Professor of Medicine at the University of Vermont Larner College of Medicine. Dr. Vahdat earned her medical degree from Mount Sinai School of Medicine, completed her residency in internal medicine at Yale-New Haven Hospital, and pursued fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. She is board-certified in Internal Medicine, Hematology, and Medical Oncology and is widely respected for her leadership in breast cancer research and clinical care.

A leader in translational and clinical research, Dr. Vahdat has focused her work on antiangiogenic therapies, circulating tumor cells, and new agents for the treatment of aggressive breast cancer subtypes. She has been principal investigator on multiple clinical trials evaluating innovative therapies that have advanced treatment standards for metastatic and high-risk breast cancers. Her research has been widely published, and she is recognized for her expertise in integrating new science into clinical practice, offering patients access to cutting-edge therapies.

In addition to her research and clinical work, Dr. Vahdat is a dedicated mentor and educator who has trained fellows and junior faculty in both clinical care and clinical trial design. She has held leadership positions at major academic cancer centers, including Weill Cornell Medicine and Duke Cancer Institute, where she built strong clinical and research programs in breast oncology. Through her commitment to innovation, patient-centered care, and mentorship, Dr. Linda Vahdat continues to advance the treatment of breast cancer and shape the future of oncology.